ABBEY HENDERSHOTT: Open Payments
NPI 1255859435 · ENGLEWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,200 in 118 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $598 · 2025 $2,200
Food & beverage: $2,101Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $490 |
| AstraZeneca Pharmaceuticals LP | 11 | $263 |
| ABBVIE INC. | 16 | $211 |
| Astellas Pharma US Inc | 5 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $156 |
| Amgen Inc. | 6 | $101 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Lilly USA, LLC | 5 | $74 |
Products named: Ozempic, VRAYLAR, AIRSUPRA, Kerendia, REXULTI, Veozah, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across OH — which companies pay providers there.
